5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.22%
Negative revenue growth while STERV.HE stands at 3.08%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
5.30%
Gross profit growth at 50-75% of STERV.HE's 7.69%. Martin Whitman would question if cost structure or brand is lagging.
4125.00%
EBIT growth above 1.5x STERV.HE's 23.24%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
4125.00%
Operating income growth above 1.5x STERV.HE's 23.24%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1033.33%
Positive net income growth while STERV.HE is negative. John Neff might see a big relative performance advantage.
972.21%
Positive EPS growth while STERV.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
972.21%
Positive diluted EPS growth while STERV.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
7.56%
Share change of 7.56% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
7.56%
Diluted share change of 7.56% while STERV.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-214.29%
Negative OCF growth while STERV.HE is at 63.01%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-372.22%
Negative FCF growth while STERV.HE is at 148.37%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-9.55%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-9.55%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-9.55%
Negative 3Y CAGR while STERV.HE stands at 26.36%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-62.18%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-62.18%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-62.18%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
249.37%
Positive 10Y CAGR while STERV.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
249.37%
Positive 5Y CAGR while STERV.HE is negative. John Neff might view this as a strong mid-term relative advantage.
249.37%
3Y net income/share CAGR above 1.5x STERV.HE's 117.67%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.33%
Inventory is declining while STERV.HE stands at 0.57%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.65%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
3.01%
Positive BV/share change while STERV.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-0.53%
We’re deleveraging while STERV.HE stands at 6.05%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.